Clozapine and all-cause mortality in treatment-resistant schizophrenia: a historical cohort study.

Clozapine reduces the risk of mortality in patients who meet criteria for TRS. We provide further evidence that improving access to clozapine in TRS is likely to reduce the mortality gap in schizophrenia.